Peer recovery support services to help individuals with opioid use disorder start medication treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to enhance the initiation of medications for opioid use disorder (MOUD) among individuals seeking inpatient treatment at Maryland Treatment Centers. By leveraging peer recovery support services (PRSS), the study seeks to address the low rates of MOUD initiation and retention, which are critical for reducing the risk of relapse and overdose. The intervention will focus on individuals diagnosed with opioid use disorder who are currently in residential treatment, aiming to improve their access to and engagement with MOUD. The study builds on an existing parent grant that focuses on retention in treatment, expanding its scope to include initiation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18+ (inclusive)
* Meets diagnostic criteria for OUD
* Currently seeking inpatient treatment at Maryland Treatment Centers program
* English speaking
* Willing and able to provide informed consent
* Able to obtain MOUD through insurance.

Exclusion Criteria:

* Having been prescribed and taken a maintenance dose of sublingual buprenorphine or methadone within 14 days of entering the current inpatient treatment episode
* received a dose of XR-buprenorphine or XR-naltrexone within 45 days of entering the current inpatient treatment episode.

Where it's running

• Maryland Treatment Centers
  Baltimore, Maryland, United States Recruiting

Study contacts

• Study coordinator: Kevin R Wenzel, PhD
• Email: KWenzel@marylandtreatment.org
• Phone: 4102331400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CBD for Opioid Dependence and Pain on Buprenorphine

  This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

  Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

• Cebranopadol for opioid withdrawal in adults with chronic pain

  This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.

  Recruiting at 2 sites Phase 2 Adneuris Therapeutics, Inc. · North Canton, Ohio and 1 other locations · NCT07874620

• emPath platform pilot to link and keep adults with opioid use disorder in care in Durham

  This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.

  Recruiting Duke University · Durham, North Carolina · NCT07810322

• CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand

  This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.

  Recruiting Phase 1 Yale University · New Haven, Connecticut · NCT07800520

• STORC: Training a support person plus patient navigation after birth

  We’re testing whether training a designated support person and using patient navigation after delivery helps people with opioid use disorder build recovery resources and stay in treatment.

  Recruiting Friends Research Institute, Inc. · Philadelphia, Pennsylvania · NCT07787039

• Personalized Addiction Treatment Enhancement for Opioid Use Disorder

  A digital platform run by peer recovery supporters will be tested to help adults with opioid use disorder who are on buprenorphine or methadone stay in treatment and improve outcomes.

  Recruiting Rhode Island Hospital · Providence, Rhode Island · NCT07778394

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.